David Rescott
Stock Analyst at Baird
(3.90)
# 567
Out of 4,784 analysts
50
Total ratings
59.52%
Success rate
7.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Outperform | $707 → $600 | $491.84 | +21.99% | 2 | Mar 18, 2025 | |
| PEN Penumbra | Maintains: Buy | $285 → $325 | $267.56 | +21.47% | 26 | Feb 19, 2025 | |
| MDT Medtronic | Maintains: Neutral | $90 → $91 | $87.63 | +3.85% | 4 | Feb 19, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $107 → $109 | $103.94 | +4.87% | 2 | Oct 31, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $66 → $72 | $39.13 | +84.00% | 3 | Oct 31, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $73 → $68 | $70.91 | -4.10% | 3 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $90 → $91 | $99.36 | -8.41% | 4 | Jul 25, 2024 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $14.04 | +85.19% | 6 | Dec 22, 2023 |
Intuitive Surgical
Mar 18, 2025
Maintains: Outperform
Price Target: $707 → $600
Current: $491.84
Upside: +21.99%
Penumbra
Feb 19, 2025
Maintains: Buy
Price Target: $285 → $325
Current: $267.56
Upside: +21.47%
Medtronic
Feb 19, 2025
Maintains: Neutral
Price Target: $90 → $91
Current: $87.63
Upside: +3.85%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $107 → $109
Current: $103.94
Upside: +4.87%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $66 → $72
Current: $39.13
Upside: +84.00%
Edwards Lifesciences
Oct 25, 2024
Maintains: Neutral
Price Target: $73 → $68
Current: $70.91
Upside: -4.10%
Boston Scientific
Jul 25, 2024
Maintains: Outperform
Price Target: $90 → $91
Current: $99.36
Upside: -8.41%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $14.04
Upside: +85.19%